WGS (genedx.com) Company Net Income

Corporate emblem and logo of genedx.com (WGS)

GeneDx Holdings Corp. (WGS) net income on this GURU.Markets chart reflects a trend where the -0.10 indicator expresses the metric level. Growth is driven by Big Data monetization through the licensing of mutation databases. Stability is supported by logistics optimization and cloud computing, while operational risks are mitigated by a shift toward high-margin genome sequencing, which offsets pressure from insurance companies.

WGS - genedx.com Net Income over the range 04/28/2023 - 11/01/2026

Financial and market metric breakdowns for GeneDx (WGS)

- stock quotes and analyst forecast:
Share Price GeneDx Corp|WGS - Analyst Consensus Forecast
- business market valuation indicators:
Market Value GeneDx Corp|WGS - Enterprise Value
- balance sheet equity data:
Equity per Share GeneDx|WGS - Company Net Assets|Capitalization to Book Value Ratio genedx.com|WGS - Cumulative Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio GeneDx Holdings Corp.|WGS - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital GeneDx Holdings|WGS - Company Debts|Debts to Book Value GeneDx Corp|WGS - Company Long-Term Debt|Company Short-Term Debt GeneDx|Immediate Liquidity Ratio genedx.com
- earnings and market ratios statistics:
WGS - Net Profit
Basic company analysis:WGS GeneDx Corp
Manufactured products of GeneDx Holdings

Amid aggressive dumping in the genetic analysis sector, GeneDx Holdings Corp. faces the risk of margin erosion due to the competition for hospital contracts. The dynamics of the company's excess income reflect management's actual ability to generate net cash flow after covering all operating expenses, allowing investors to assess the business's resilience to price wars through the stability of this curve.

Main competitors

Company Profit TEM|QGEN (Qiagen N.V.) - Net Profit|Company Net Income ionispharma.com IONS|Net Profit RGEN|Avidity Biosciences Inc - Company Profit|CRISPR Therapeutics Corp - Net Income|RARE: Company Profit|BEAM: Net Income|Final Profit SRPT (sarepta.com)|TWST: Net Profit|10x Genomics Inc - Final Profit|Company Net Income Intellia|Company Net Income Stoke Corp STOK|Company Net Income BioLife Solutions, Inc. (BLFS)|Company Net Income WVE (wavelifesciences.com)|Net Profit MAZE (Maze Therapeutics)|SION: Company Profit|Prime Medicine Corp - Net Profit|Net Financial Result Taysha Corp TSHA|uniQure N.V. (QURE) - Company Net Income|Company Profit MGTX|RGNX (REGENXBIO) - Net Profit|SLDB - Annual Net Income|Company Net Income Ocugen Corp (OCGN)|Net Financial Result PacBio Corp|Benitec Biopharma Inc. - Net Income|Final Profit DSGN|Rocket Pharmaceuticals, Inc. - Net Profit|4DMT (FDMT) - Net Income|lexeotx.com (LXEO) - Company Net Income|Company Net Income Korro Bio (KRRO)|Company Net Income Editas Medicine, Inc.|SLN: Final Profit|Company Net Income ProQR Therapeutics N.V. (PRQR)|CDXS: Profit After Tax|Sangamo - Net Income|Net Financial Result Nautilus Biotechnology, Inc. (NAUT)|MGX: Net Income|Precision BioSciences Inc. (DTIL) - Net Income|GBIO: Net Profit|Annual Net Income Boundless Bio Inc. BOLD|Company Net Income Exicure Inc.|Celsion Corporation (IMNN) - Net Financial Result|Net Profit PHIO|mustangbio.com - Company Profit|Company Net Income TransCode Therapeutics, Inc. RNAZ|BNGO: Company Profit|Applied DNA - Net Profit|BLUE - Net Profit|IPA: Net Profit|Annual Net Income omegatherapeutics.com OMGA|OMIC (Singular Genomics) - Net Profit|Company Net Income Regulus Therapeutics, Inc. RGLS|Company Net Income Syros (SYRS)|Telesis Bio, Inc - Company Profit|Net Profit TCON (TRACON Pharmaceuticals)|unitybiotechnology.com (UBX) - Company Net Income